TherapeuticsMD | TXMD - Ebit

Stock Price
2.33
Daily Change
0.04 1.53%
Monthly
2.88%
Yearly
130.20%
Q1 Forecast
2.17

TherapeuticsMD reported $-1.77M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
TherapeuticsMD USD -1.77M 699K Sep/2023